Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes.
about
The pathophysiology of thrombocytopenia in chronic liver diseaseJunín virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling.Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-α and TNF-α in systemic lupus erythematosus.Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case reportType I interferon is a therapeutic target for virus-induced lethal vascular damage.Safety, Tolerability, and Immunogenicity of InterferonsBoth viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients.Antiproliferative Properties of Type I and Type II Interferon.Management of Hepatitis C Antiviral Therapy Adverse Effects.Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans.New treatments for chronic hepatitis C: an overview for paediatricians.The interferon-alpha revival in CML.IFNA2: The prototypic human alpha interferon.Current trends in the treatment of hepatitis C: interventions to avoid adverse effects and increase effectiveness of anti-HCV drugs.Expression and functionality of type I interferon receptor in the megakaryocytic lineage.Recombinant interferon alpha (rIFN alpha-2b) may retard progression of early primary myelofibrosis.Platelets in Immune Response to Virus and Immunopathology of Viral Infections.
P2860
Q26749277-37511C58-581F-4B31-8E13-6FC413159810Q33389296-A2782671-491C-41E0-A0C7-367BEE491888Q33393060-132A6499-278C-4471-B3D4-45E29F80D303Q33409032-ACA05308-FCC9-4DEC-86ED-E2398EE01D5EQ33413883-4F6A4AF9-5981-4D69-99BA-DE549FDDA82FQ33415686-BFA7C3E8-5315-4072-8194-FEA28A968BAEQ33435810-DF57507E-18F6-4DEB-9791-72FA5EA2F2ACQ33785818-23CAD7DB-0248-47AC-8453-F0CF4688B13DQ34007700-5F755C0F-5E47-454B-9253-35EDAAB69325Q34538771-DD180279-187D-4397-A72E-C18DFFF5C2CEQ37604501-C5CC211F-F802-4392-BF32-4267251A7745Q38087506-F18F8A82-71CA-46AB-B171-27B258463E58Q38282842-2CC66ED4-5D70-41EB-93C8-31AEC1A3C5D1Q38392694-B3B5818A-62B3-41F4-BF48-25B4F9CF5923Q38486383-9E832035-8AA3-477C-B9A2-7169227E345BQ39092871-16D1DC24-62DF-4426-9216-DDE3DB2723EEQ39434066-75CE4479-F260-4292-876B-D96B0B1CA70DQ47805850-F04E86F3-1E83-438E-AAB6-CB3964C0C183Q55004062-CB2704DF-547E-48A7-82E9-B59C6E42CC41
P2860
Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Interferon-alpha 2b-induced th ...... tosis in human megakaryocytes.
@ast
Interferon-alpha 2b-induced th ...... tosis in human megakaryocytes.
@en
type
label
Interferon-alpha 2b-induced th ...... tosis in human megakaryocytes.
@ast
Interferon-alpha 2b-induced th ...... tosis in human megakaryocytes.
@en
prefLabel
Interferon-alpha 2b-induced th ...... tosis in human megakaryocytes.
@ast
Interferon-alpha 2b-induced th ...... tosis in human megakaryocytes.
@en
P2093
P1433
P1476
Interferon-alpha 2b-induced th ...... tosis in human megakaryocytes.
@en
P2093
Akiko Yamane
Hidenori Suzuki
Mamoru Ito
Takanori Nakamura
Yasuo Ikeda
Yasuyuki Ohnishi
Yoshitaka Miyakawa
P304
P356
10.1182/BLOOD-2007-12-125906
P407
P577
2008-06-03T00:00:00Z